103 results
Page 3 of 6
8-K
EX-99.1
qgewpgk n13mda655ij
3 Mar 21
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year
4:01pm
8-K
EX-99.1
asoh4
5 Feb 21
Soleno Therapeutics Provides Recap of Key Opinion Leader Webinar on DCCR for Treatment of Prader-Willi Syndrome
8:01am
8-K
EX-10.1
iob crgwcu
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-99.1
3as8d9i3 b3klodj7t
10 Nov 20
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results
4:22pm
8-K
EX-99.1
adg4579l
10 Aug 20
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2020 Financial Results
4:09pm
424B5
2iwbe4e8xd txqj54g6v
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
4c33ffxf1x90
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.2
kzgkl4qbxgn09f
8 Jun 20
Regulation FD Disclosure
5:04pm
8-K
EX-99.1
8by 9sru5imku
8 Jun 20
Regulation FD Disclosure
5:04pm
8-K
EX-99.1
nxolhyhb5smtj2 7oj2t
12 May 20
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
jp7 gkjeq1
4 Mar 20
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
4:17pm
8-K
EX-99.1
y7mhbeuo11lj16s
10 Jan 20
Regulation FD Disclosure
5:16pm
8-K
EX-99.1
whl pm18zgpe4i
13 Nov 19
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2019 Financial Results
6:10am
424B5
ntc dddp7td2
25 Oct 19
Prospectus supplement for primary offering
12:00am